Food for Special Medical Purpose market size is forecast to reach $26.6 billion by 2030; growing prevalence of chronic diseases, growing geriatric population and demand for medical nutrition are driving the growth of the market.

The Food for Special Medical Purpose (FSMP) Market size is estimated to reach $26.6 billion by 2030, growing at a CAGR of 7.5% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Food for Special Medical Purpose Market– By Condition (Chronic Diseases, Digestive Disorders, Cancer, Neurological Disorders, Metabolic Disorders and Others), By Form (Oral, Enteral, and Others.), By Target Consumers (Infants & Young Children, Adult, Geriatric), By End Users (Hospitals and Clinics, Nursing Homes and Homecare Settings) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030.”

In the healthcare sector, FSMP plays a critical role in providing specialized nutrition for patients with specific medical conditions such as malnutrition, diabetes and gastrointestinal disorders. The increasing prevalence of chronic diseases, the growing geriatric population, and the rising need for medical nutrition are key drivers of the growth of the market.

North America accounted for the largest share of in the Food for Special Medical Purpose (FSMP) Market in 2023 due to its advanced healthcare infrastructure, high awareness levels, and significant prevalence of chronic diseases and aging populations. According to data from Urban Institute, the number of Americans ages 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The region benefits from stringent regulatory frameworks that ensure the quality and efficacy of FSMP products, making them trusted solutions for various medical conditions. Additionally, the robust healthcare reimbursement systems in countries like the United States and Canada support patient accessibility to FSMP products. The increasing adoption of FSMP in hospitals, long-term care facilities and homecare settings further drives market demand.

A Survey on Digestive Health of Indian families by ITC revealed that 56% of Indian families have reported digestive health issues. Increasing awareness of digestive disorders such as Crohn’s disease, irritable bowel syndrome (IBS) and celiac disease boosts the demand for FSMP products. These conditions often require specialized nutrition to manage symptoms, ensure proper nutrient absorption, and improve patients’ quality of life. Advances in diagnostics and a growing focus on gut health have led to earlier detection and management of these disorders, driving demand for tailored FSMP solutions. Products such as gluten-free, low-FODMAP, and prebiotic-enriched formulas cater to the specific needs of patients with digestive issues. Awareness campaigns by healthcare organizations and support groups have also played a critical role in educating the public about the benefits of medical nutrition. As digestive health continues to gain prominence in overall well-being, FSMP products designed for digestive disorders are witnessing robust growth and adoption.

The global rise in the geriatric population is a key driver of the FSMP market as aging individuals often face unique nutritional challenges due to declining metabolic efficiency, reduced appetite and age-related health conditions. The United Nations Department of Economic and Social Affairs (UN DESA) reports that the global population aged 65 and older is projected to increase to 1.5 billion by 2050. This means that by 2050, 1 in 6 people in the world will be aged 65 or older. Elderly individuals frequently require specialized nutrition to address conditions such as sarcopenia, osteoporosis and dysphagia. FSMP products tailored for the elderly include high-protein formulas, nutrient-dense supplements and easy-to-swallow textures to cater to their specific needs. With increasing awareness about the importance of maintaining health and independence in old age, demand for FSMP among this demographic is surging. Governments and healthcare organizations are also emphasizing elder care programs, further promoting FSMP adoption. 

Key companies profiled in the FSMP Market are Nestlé Health Science, Danone, Abbott Laboratories, Fresenius Kabi, Mead Johnson Nutrition, Reckitt Benckiser, Hero Group, Dsm-firmenich, Vitaflo, and Others.

Nutritional Premixes Market - The Nutritional Premixes Market is estimated to reach $2,849.5 million by 2027, growing at a CAGR of 6.9% over the forecast period 2022-2027. The rising incidence of chronic diseases and rising healthcare costs have led to an increase in the usage of dietary supplements, which has raised the demand for Nutritional Premixes.

Nutrition Products For Cachexia Market- Nutrition Products For Cachexia Market size is estimated to reach $2.9 billion by 2027, growing at a CAGR of 7.3% during the forecast period 2022-2027. The rising prevalence of cancer and cancer cachexia cases is set to drive the Nutrition Products For Cachexia Market.

Parenteral Nutrition Market - Parenteral Nutrition Market Size is forecast to reach $ 10,182.80 Million by 2030, at a CAGR of 7.10% during forecast period 2024-2030. Growing awareness programs initiated both by the governmental and private organizations have increased knowledge about chronic diseases among the mass, thereby escalating the parenteral nutrition market scope.